Source:http://linkedlifedata.com/resource/pubmed/id/11207245
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-3-14
|
pubmed:abstractText |
Based on the relative expression of CD11c and CD1a, we previously identified subsets of dendritic cells (DCs) or DC precursors in human peripheral blood. A CD1a(+)/CD11c(+) population (CD11c(+) DCs), also called myeloid DCs, is an immediate precursor of Langerhans cells, whereas a CD1a(-)/CD11c(-) population (CD11c(-) DCs), sometimes called lymphoid DCs but better known as plasmacytoid DCs, is composed of type I IFN (IFN-alpha beta)-producing cells. Here, we investigate the effects of IFN-alpha beta and IFN-gamma as well as other cytokines on CD11c(+) and CD11c(-) DC subsets, directly isolated from the peripheral blood, instead of in vitro-generated DCs. IFN-gamma and IFN-alpha, rather than GM-CSF, were the most potent cytokines for enhancing the maturation of CD11c(+) DCs. Incubation of CD11c(+) DCs with IFN-gamma also resulted in increased IL-12 production, and this IL-12 allowed DCs to increase Th1 responses by alloreactive T cells. In contrast, IFN-alpha did not induce IL-12 but, rather, augmented IL-10 production. IFN-alpha-primed matured CD11c(+) DCs induced IL-10-producing regulatory T cells; however, this process was independent of the DC-derived IL-10. On the other hand, IFN-alpha by itself neither matured CD11c(-) DCs nor altered the polarization of responding T cells, although this cytokine was a potent survival factor for CD11c(-) DCs. Unlike IFN-alpha, IL-3 was a potent survival factor and induced the maturation of CD11c(-) DCs. The IL-3-primed CD11c(-) DCs activated T cells to produce IL-10, IFN-gamma, and IL-4. Thus, CD11c(+) and CD11c(-) DC subsets play distinct roles in the cytokine network, especially their responses to IFNs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
166
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2961-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11207245-Cell Differentiation,
pubmed-meshheading:11207245-Cell Survival,
pubmed-meshheading:11207245-Cells, Cultured,
pubmed-meshheading:11207245-Cytokines,
pubmed-meshheading:11207245-Dendritic Cells,
pubmed-meshheading:11207245-Hematopoietic Stem Cells,
pubmed-meshheading:11207245-Humans,
pubmed-meshheading:11207245-Immunophenotyping,
pubmed-meshheading:11207245-Interferons,
pubmed-meshheading:11207245-Leukocytes, Mononuclear,
pubmed-meshheading:11207245-Receptors, Cytokine,
pubmed-meshheading:11207245-T-Lymphocyte Subsets,
pubmed-meshheading:11207245-T-Lymphocytes, Helper-Inducer
|
pubmed:year |
2001
|
pubmed:articleTitle |
Differential regulation of human blood dendritic cell subsets by IFNs.
|
pubmed:affiliation |
First Department of Internal Medicine, Kansai Medical University, Osaka, Japan. amakawa@takii.kmu.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|